Authors

Alexander Mohler, Miami Cancer InstituteFollow
Belkys Salinas, Miami Cancer InstituteFollow
Nicholas Lambrou, Miami Cancer InstituteFollow
Karissa Nazur, Miami Cancer InstituteFollow
Yazmin Odia, Miami Cancer InstituteFollow
Rupesh Kotecha, Miami Cancer InstituteFollow

PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series

Publication Date

8-19-2021

Presented At:

2021 SNO Conference on Brain Metastases

Content Type

Poster

Comments

Abstract associated with this poster and presented at the same conference can be found at: https://scholarlycommons.baptisthealth.net/se-all-publications/4048/

Citation

Mohler, Alexander; Salinas, Belkys; Lambrou, Nicholas; Nazur, Karissa; Odia, Yazmin; and Kotecha, Rupesh, "PARP Inhibitor Tolerability and Impact on Progression-Free Survival in Patients with High-Grade, Ovarian Carcinoma with Brain Metastasis: A Case-Series" (2021). All Publications. 4049.
https://scholarlycommons.baptisthealth.net/se-all-publications/4049